Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A. [PDF]
Mastrapasqua M +13 more
europepmc +1 more source
Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies. [PDF]
Rawls A +5 more
europepmc +1 more source
Quynh Nguyen,*,1 Kenji Rowel Q Lim,*,1 Toshifumi Yokota,1,21Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada; 2The Friends of Garrett Cumming Research & Muscular Dystrophy Canada,
Nguyen Q, Lim KRQ, Yokota T
doaj
A rare case of arrhythmogenic right ventricular cardiomyopathy associated with LAMA2 mutation: A case report and literature review. [PDF]
Wang Y, Fang Y, Zhang D, Li Y, Luo S.
europepmc +1 more source
Lysosomes and the pathogenesis of merosin-deficient congenital muscular dystrophy. [PDF]
Smith SJ +6 more
europepmc +1 more source
Clinico-genetic heterogeneity in Pakistani families affected with muscular dystrophies. [PDF]
Ahmad R +5 more
europepmc +1 more source
LAMA2 Triple Variant in a Mexican Child with Congenital Muscular Dystrophy. [PDF]
Pinto-Escalante D +4 more
europepmc +1 more source
Merosin deficient congenital muscular dystrophy type 1A: An international workshop on the road to therapy 15-17 November 2019, Maastricht, the Netherlands. [PDF]
Smeets HJM +4 more
europepmc +1 more source
High Anion Gap Metabolic Acidosis (HAGMA) After Levetiracetam Administration in an 11-Year-Old Boy With Laminin-α2-Deficiency-Associated Muscular Dystrophy and Epilepsy. [PDF]
Beusker PE +3 more
europepmc +1 more source
Advances and clinical potential of epigenome editing. [PDF]
Choi I, Kim S, Baek I.
europepmc +1 more source

